Table 2

Secondary performance measures for the Improving Care for Cardiovascular Disease in China-atrial fibrillation project

ReferenceTitle of performance measureProportion, %
(numerator/denominator)
22 Proportion of non-valvular AF patients who had a CHADS2 score reported15.0 (3422/22 864)
7, 22 Proportion of non-valvular AF patients who had a CHA2DS2-VASc score reported19.2 (4397/22 864)
7, 22 Proportion of AF patients who have a documented resting heart rate of <80 bpm closest to discharge65.0 (7140/10 989)
7, 22 Proportion of AF patients receiving anticoagulation therapy education89.4 (10 941/12 243)
7, 22 Proportion of AF patients receiving conventional medical education89.3 (25 547/28 615)
20 Proportion of AF patients with indication prescribed aldosterone antagonist at discharge*72.2 (888/1230)
7, 22 Proportion valvular AF patients prescribed warfarin at discharge52.4 (2010/3838)
20 Proportion of AF patients who are given smoking cessation advice or counselling22.5 (1263/5623)
Composite scores of secondary performance measures51.4 (55 608/108 266)
  • *Indications refer to acute myocardial infarction patients with left ventricular ejection fraction <40% or heart failure or diabetes mellitus; or the heart failure patients with left ventricular ejection fraction <35%.